Siena, Italy

Cesare Pellerano

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cesare Pellerano. Retrieved from https://idiyas.com/inventor/cesare-pellerano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cesare Pellerano: Innovator in Amyloid-Related Conditions

Introduction

Cesare Pellerano is a notable inventor based in Siena, Italy. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning amyloid-related conditions. His innovative work has the potential to impact the lives of many individuals affected by these conditions.

Latest Patents

Pellerano holds a patent for "Compounds and methods for diagnosing and treating amyloid-related conditions." This invention provides methods for diagnosing and treating conditions characterized by the binding or aggregation of amyloid fibrils. More specifically, it relates to the use of quinolinehydrazone compounds for diagnosing and treating amyloidotic conditions, as well as serving as an antioxidant. He has 1 patent to his name.

Career Highlights

Cesare Pellerano has worked with Pharmacia & Upjohn Company, where he has been able to apply his expertise in the development of innovative solutions for medical challenges. His work has been instrumental in advancing the understanding and treatment of amyloid-related diseases.

Collaborations

Throughout his career, Pellerano has collaborated with esteemed colleagues such as Thomas J Raub and Geri A Sawada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Cesare Pellerano's contributions to the field of amyloid-related conditions highlight the importance of innovation in medical science. His work not only advances diagnostic and treatment methods but also exemplifies the collaborative spirit of research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…